WELL Health Technologies Corp【WELL】株式ニュース

WELL Health Improves Guidance Based on WELL Canada Achieving $100 Million in Annualized Adjusted EBITDA Run-Rate Ahead of ScheduleJune 2, 2026 6:30 AM
NewsfileWELL has reached its goal of $100 million in annualized Adjusted EBITDA(1) run-rate for WELL Canada, three calendar quarters ahead of schedule, driven by strong organic growth across WELL Clinics and WELLSTAR together with two accretive acquisitions.WELL had previously guided a $100 million annualized Adjusted EBITDA(1) run-rate by Q1-2027 on approximately $800 million of revenue. The Company has delivered it on approximately $700 million of revenue, implying an Adjusted EBITDA Margin(1) of approximately 14% - roughly 180 basis points ahead of prior guidance.On June 1, 2026, WELL closed two complementary, immediately accretive acquisitions in Ontario and Québec, focused on diagnostic imaging and procedural care: 100% of the OID Group and approximately 65% controlling interest in UnionMD. The Company paid approximately $115 million at closing for both acquisitions, expanding its Canadian Clinics network to approximately 270 clinics nationally. The total purchase price for these two transactions could amount to $160 million, inclusive of future earn-outs and vendor take-back financing.The two acquisitions generated combined Adjusted EBITDA(1) of approximately $22 million in 2025, reflecting Adjusted EBITDA Margins(1) of well over 25%, and bringing WELL Canadian Clinics to well over $80 million in annualized Adjusted EBITDA(1) run-rate.On the strength of this performance and the contribution of the completed acquisitions, WELL now expects to exceed the top end of its previously announced 2026 Adjusted EBITDA(1) guidance range of $175 million to $185 million. The Company intends to provide a formal update to its 2026 outlook in connection with announcing its second quarter financial results.Vancouver, British Columbia--(Newsfile Corp. - June 2, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, today announced that it has achieved its goal of $100 million in annualized Adjusted EBITDA(1) run-rate for its WELL Canada segment, three calendar quarters ahead of the timeline it had previously guided to, and at materially better margins. This milestone reflects the combined strength of WELL's organic growth and its disciplined acquisition strategy across the Canadian business. In conjunction with reaching this milestone, WELL also announced the closing of two complementary, immediately accretive clinical platform acquisitions: a network of outpatient diagnostic imaging clinics in Ontario operating primarily under the Ontario Imaging Diagnostics brand ("OID Group"), and a majority controlling interest in JDMD Inc. ("UnionMD"), one of Québec's largest multi-disciplinary healthcare platforms.These two acquisitions generated combined Adjusted EBITDA(1) of approximately $22 million in 2025 reflecting Adjusted EBITDA Margins(1) of well over 25%. With these acquisitions, WELL's Canadian Clinics network has expanded to approximately 270 clinics, with approximately 2,350 billable healthcare providers. Together, they are expected to bring WELL Canadian Clinics to well over $80 million in annualized Adjusted EBITDA(1) run-rate and WELL Canada, which includes Canadian Clinics, WELLSTAR and CYBERWELL, to over $100 million in annualized Adjusted EBITDA(1) run-rate. Both acquisitions were fully funded through the Company's cash on hand and existing credit facilities.Reaching and exceeding $100 million in annualized Adjusted EBITDA(1) run-rate for WELL Canada represents a key milestone for the Company. Through a combination of strong organic growth and disciplined acquisitions, WELL has firmly reached this goal three calendar quarters earlier than previously guided. The Company had previously guided that it expected to reach $100 million in annualized Adjusted EBITDA(1) run-rate for WELL Canada by the first quarter of 2027 on associated revenue of approximately $800 million. WELL has delivered this run-rate on associated revenue of approximately $700 million, implying an Adjusted EBITDA Margin(1) of approximately 14% - approximately 180 basis points ahead of the margin implied by the Company's prior guidance.On the strength of this performance and the contribution of these completed acquisitions, WELL expects to exceed the top end of its previously announced 2026 Adjusted EBITDA(1) guidance range of $175 million to $185 million. The Company intends to provide a formal update to its 2026 outlook in connection with announcing its second quarter financial results.Hamed Shahbazi, Chairman and CEO of WELL, commented, "Reaching $100 million in annualized Adjusted EBITDA run-rate for WELL Canada three calendar quarters ahead of schedule, and at materially better margins than we had guided to, is a milestone we are very proud of. What makes it especially meaningful is how we got here. This is the result of total performance across our Canadian business - strong organic growth at both WELL Clinics and WELLSTAR, complemented by disciplined, accretive acquisitions. Our model is working, and we are reaching our goals faster and more profitably than planned. We now turn much of our attention to integration and operational execution across the platform. We look forward to sharing more with our second quarter results."In Ontario, WELL has acquired the OID Group, a network of outpatient diagnostic imaging clinics operating primarily under the Ontario Imaging Diagnostics brand. In Québec, WELL has acquired a majority controlling interest in UnionMD, one of the province's largest and multi-disciplinary healthcare platforms, a procedure-first business. Both acquisitions achieved Adjusted EBITDA Margins(1) of well over 25% in 2025. The aggregate purchase price paid at closing of $115 million for these two transactions was fully funded through proceeds from the newly expanded and extended senior secured credit facility arranged with a syndicate of lenders led by Royal Bank of Canada, JPMorgan Chase Bank, N.A., and Toronto-Dominion Bank in January 2026. The total purchase price for these two transactions could amount up to $160 million, inclusive of future earn-outs and vendor take-back financing.Dr. Michael Frankel, President of Canadian Clinics, commented, "Both of these acquisitions bring strong, well-established clinical teams into the WELL network and reflect the depth of talent that exists across the Canadian healthcare landscape. We look forward to bringing these clinics into the WELL ecosystem, leveraging our shared services infrastructure and technology platforms to enhance operational efficiency and the experience for both patients and providers."Beyond their standalone contribution, both acquisitions are expected to benefit from WELL's shared services infrastructure, technology platforms, and proven clinic operating model. WELL has identified a range of opportunities to enhance performance across the acquired platforms, including expanded capacity and other synergies across WELL's national network. The Company believes these initiatives, combined with the platforms' already strong margin profiles, will further support WELL Canada's profitability over time. WELL intends to provide additional detail on its integration and value-creation plans in connection with announcing its second quarter financial results. Footnotes:Adjusted EBITDA and Adjusted EBITDA Margin are non-GAAP financial measures. Please refer to WELL's most recent Management's Discussion and Analysis (MD&A), available under the Company's profile on SEDAR+ at www.sedarplus.ca, for further details including definitions and reconciliations to the nearest IFRS measure. WELL HEALTH TECHNOLOGIES CORP.
Per: "Hamed Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and Director About WELL Health Technologies Corp.WELL Health Technologies Corp. (TSX: WELL) is Canada's largest outpatient healthcare company and a leading provider of technology-enabled healthcare solutions. WELL is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI, and every piece of health data is protected. WELL owns and operates approximately 270 clinics in Canada, supporting more than 5 million annual patient visits. Through its subsidiary WELLSTAR, WELL provides electronic medical records, AI-powered clinical tools, patient engagement platforms and IT management services. WELL provides cybersecurity services through its CYBERWELL subsidiary. WELL is publicly-traded on the TSX under the symbol "WELL" and on the OTC Exchange under the symbol "WHTCF". To learn more, please visit: www.well.company.Forward-Looking StatementsThis news release may contain "Forward-Looking Information" within the meaning of applicable Canadian securities laws, including, without limitation: information regarding the Company's goals, strategies and growth plans; expectations regarding continued revenue and EBITDA growth; the expected benefits and synergies of completed acquisitions; 2026 guidance affirmation/improvement, long-term strategic objectives, liquidity expectations, WELL's acquisition pipeline, WELL's growth initiatives, revenue and other financial contributions from completed acquisitions, as well as information in the "Outlook" section herein. Forward-Looking Information are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-Looking Information generally can be identified by the use of forward-looking words such as "may", "should", "will", "could", "intend", "estimate", "plan", "anticipate", "expect", "believe" or "continue", or the negative thereof or similar variations. Forward-Looking Information involve known and unknown risks, uncertainties and other factors that may cause future results, performance, or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by the Forward-Looking Information and the Forward-Looking Information are not guarantees of future performance. WELL's comments expressed or implied by such Forward-Looking Information are subject to a number of risks, uncertainties, and conditions, many of which are outside of WELL 's control, and undue reliance should not be placed on such information. Forward-Looking Information are qualified in their entirety by inherent risks and uncertainties, including without limitation: adverse market conditions and the ability to complete acquisitions; risks inherent in the primary healthcare sector in general; continued patient and consumer demand for WELL's products and services; regulatory and legislative changes; that future results may vary from historical results; the inability to obtain any requisite future financing on suitable terms; any inability to realize the expected benefits and synergies from acquisitions; that market competition may affect the business, results and/or financial condition of WELL and other risk factors identified in documents filed by WELL under its profile at www.sedarplus.ca, including its most recent Annual Information Form. Except as required by securities laws, WELL does not assume any obligation to update or revise any forward-looking information, whether as a result of new information, events or otherwise.This news release contains financial outlook information (collectively, "FOI") about estimated annual run-rate revenue for WELL Canada, Adjusted EBITDA, and Adjusted EBITDA Margins all of which are subject to the same assumptions, risk factors, limitations, and qualifications as set out in the above paragraph. The actual financial results of WELL may vary from the amounts set out herein and such variation may be material. WELL and its management believe that the FOI has been prepared on a reasonable basis, reflecting management's best estimates and judgments. However, because this information is subjective and subject to numerous risks, it should not be relied on as necessarily indicative of future results. Except as required by applicable securities laws, WELL undertakes no obligation to update such FOI. FOI contained in this news release was made as of the date hereof and was provided for the purpose of providing further information about WELL's anticipated future business operations on an annual basis. Readers are cautioned that the FOI contained in this news release should not be used for purposes other than for which it is disclosed herein.Neither the TSX nor its Regulation Services Provider (as that term is defined in policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.For further information:Pardeep Sangha
Vice President, Investor Relations

WELL Health Reports Record Canadian Patient Visits and Primary Care Margin Expansion in Q1-2026April 21, 2026 7:00 AM
NewsfileWELL Canada delivered a record ~1.27 million patient visits(1) in Q1-2026, representing 33% year-over-year growth and 13% organic growth, reflecting broad-based strength across its national network.Primary Care Adjusted EBITDA(2) margins expanded to approximately 8% in Q1-2026 on a preliminary basis, up approximately 200 basis points from 6% in Q1-2025, driven by WELL's clinic transformation program and recent accretive acquisitions. Specialty Care margins continued to comfortably exceed 20%.Affiliate Clinic network expanded to 74 licensee locations, reflecting the continued build-out of WELL's ten-year strategic alliance with a large retailer that WELL partnered with in December 2024. The model is highly recurring, high-margin, and capital-light, giving physicians access to high-traffic retail locations nationally.CardiologyNow virtual visits grew 65% year-to-date, supported by expanded specialist capacity and strong referral demand, reinforcing its role as a key access point into WELL's national diagnostics network.Vancouver, British Columbia--(Newsfile Corp. - April 21, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, today reported record quarterly patient visits across its Canadian Clinics network and highlighted continued organic growth, margin expansion in its Primary Care segment, the continued scaling of its Affiliate Clinic network, and strong momentum in its CardiologyNow virtual specialty-care platform.Hamed Shahbazi, Chairman and CEO of WELL, commented, "Our Canadian Clinics network delivered another record quarter, with approximately 1.27 million patient visits and 13% organic growth reflecting the underlying health and compounding value of our platform. Beyond the headline number, we are seeing real operating leverage emerge: margins in Primary Care are expanding as our clinic transformation program takes hold, our Affiliate Clinic network continues to scale in a capital-light manner, and CardiologyNow is rapidly becoming a leading virtual specialty-care platform in Canada. Together, these are the some of the proof points that continue to give us confidence in the durability of WELL's growth."Steep Increase in Providers Drives Record Patient Visits and Continued Organic GrowthWELL delivered a record 1.27 million Canadian patient visits?¹? in Q1-2026, representing a 33% increase year-over-year and 13% organic growth. Organic growth was comprised of 8% same-clinic growth and 5% from clinic absorptions(3), reflecting strong underlying demand for primary and specialty care, improved clinic utilization, and operational efficiencies enabled by WELL's tech-enabled platforms.WELL's Canadian clinic network expanded to 253 clinics at quarter end, an addition of 33 clinics or 15% growth compared to Q1-2025, with the majority of additions completed in Ontario and Alberta, two of Canada's highest-demand healthcare markets. The Company's Canadian network now includes over 3,100 providers, up 17% year-over-year, with physicians representing the fastest-growing segment of the provider base at 22% year-over-year growth.WELL continues to maintain a strong pipeline of acquisition and clinic absorption opportunities, reinforcing its position as Canada's leading consolidator of outpatient healthcare assets.WELL Canada Patient Visits, Clinic Count and Healthcare Providers
Q1-2026Q1-2025Y/Y GrowthQuarterly Canada Patient Visits1,270,005957,03233%Canadian Clinic Counts (at quarter end)25322015%Canadian Providers (at quarter end)3,1582,71017% WELL Canada Patient Visits Q1-2026 Growth BreakdownPatient Visit GrowthY/Y GrowthSame Clinic8%Absorption(3)5%Total Organic13%Inorganic Growth20%Total Patient Visit Growth33% Primary Care Margin ExpansionOn a preliminary basis, WELL's Primary Care segment is expected to deliver Adjusted EBITDA margins(2) of approximately 8% in Q1-2026, up approximately 200 basis points from 6% in Q1-2025. The improvement reflects the combined impact of accretive acquisitions and ongoing execution of WELL's clinic transformation program. Specialty Care margins continued to comfortably exceed 20% in the quarter, underscoring the attractive economics of WELL's higher-acuity service lines.WELL's clinic transformation program is a disciplined, data-driven initiative designed to enhance efficiency, patient throughput, and profitability across clinics that are often operating at or near break-even at the time of acquisition. The program covers clinic integration, digital readiness, implementation of core technologies, and ongoing performance optimization, and is delivering measurable improvements in operating performance across WELL's network.Affiliate Clinic Network Expands to 74 Locations with National Retail Partner WELL's Affiliate Clinic network has grown to 74 licensee locations across Canada, up from 59 locations at the time WELL entered its ten-year strategic alliance with a large retailer in December 2024. The network now spans six provinces: British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and Québec, with expansion achieved through a combination of greenfield clinic development and the reopening of previously closed locations formerly operated by the prior provider.Affiliate clinics are physician or third-party-owned and operated practices located within WELL-managed clinic spaces inside high-traffic retail locations. These practices retain full control over their clinical and staffing operations while benefiting from WELL-controlled real estate, national scale, and optional access to WELL's digital and operational support tools. The model is highly recurring, high-margin, and capital-light, and also represents an attractive cross-sell channel for WELLSTAR's digital health solutions, including EMR, billing and revenue cycle management, patient engagement, and AI-enabled clinical and administrative tools.Strong Momentum in CardiologyNow Virtual VisitsCardiologyNow is WELL Health Diagnostics' rapid-access virtual cardiology consultation service, powered by a WELLSTAR digital platform, which connects patients and primary care providers with specialty care and diagnostic imaging. The platform delivered a 65% year-to-date increase in consultation billings compared to the same period last year.Growth has been driven by the addition of 35 new cardiologists and internal medicine physicians, expanded referral intake from WELL's primary care network, and increased service demand. WELL's recently announced partnership with AliveCor is expected to further contribute to this momentum in Q2-2026 and beyond, expanding access to remote cardiac monitoring and enabling timely cardiologist oversight through AI-powered ECG technology.As Canada's largest cardiology and medical diagnostic network, WELL's platform serves as a key access point into its broader diagnostics ecosystem, enabling timely virtual consultations and efficiently directing patients into its national network of diagnostic centres for follow-up testing and care. WELL plans to continue scaling the platform through additional recruitment of cardiologists and internal medicine specialists.Dr. Paul Kannampuzha, Chief Cardiology Officer at WELL, commented, "Wait times for specialist consultations remain a significant barrier to timely cardiac care in Canada. CardiologyNow was built to close that gap, and the momentum we are seeing in Q1 reflects the strength of this model. By combining rapid-access virtual consultations with a growing roster of cardiologists and seamless integration into our national diagnostic network, we are able to get patients in front of the right specialist quickly and move them into testing and treatment without delay."Footnotes:(1) Patient visits are defined by any interaction a patient has with a WELL practitioner through all sources and channels, including in-person, virtual, diagnostic testing consultations, and asynchronous physician consultations. Patient visit metrics are preliminary and subject to change from the Company's final Q1-2026 reported metrics.(2) Preliminary financial results are subject to change and may differ materially from the Company's final reported Q1-2026 financial results. Adjusted EBITDA is a non-GAAP measure. EBITDA represents net income (loss) before interest, taxes, depreciation and amortization. The Company defines Adjusted EBITDA as EBITDA, adjusted for items not reflective of ongoing operating performance, including transaction, restructuring and integration costs, share-based payments, time-based earn-out expense, changes in fair value, foreign exchange gains/losses, and certain revenue recognition adjustments under IFRS 15. Adjusted EBITDA should not be considered an alternative to net income (loss) or cash flow from operating activities determined in accordance with IFRS.(3) Clinic Absorptions refers to clinics joining WELL's clinic network for nominal consideration, contributing to organic growth. WELL HEALTH TECHNOLOGIES CORP.Per: "Hamed Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and DirectorAbout WELL Health Technologies Corp.WELL Health Technologies Corp. (TSX: WELL) is Canada's largest outpatient healthcare company and a leading provider of technology-enabled healthcare solutions. WELL is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI, and every piece of health data is protected. WELL owns and operates more than 250 clinics in Canada, supporting more than 4 million annual patient visits. Through its subsidiary WELLSTAR, WELL provides electronic medical records, AI-powered clinical tools, patient engagement platforms and IT management services. WELL provides cybersecurity services through its CYBERWELL subsidiary. WELL is publicly traded on the TSX under the symbol "WELL" and on the OTC Exchange under the symbol "WHTCF." To learn more, please visit: www.well.company.Forward-Looking StatementsThis news release contains "Forward-Looking Information" within the meaning of applicable Canadian securities laws, including statements regarding preliminary Q1-2026 financial results and patient visits, the continued expansion of WELL's Affiliate Clinic network, the growth of CardiologyNow, scaling the platform through additional recruitment of cardiologists and internal medicine specialists and future expansion plans. Forward-Looking Information is based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive uncertainties and contingencies outside of WELL's control. Such Forward-Looking Information is not a guarantee of future performance. WELL's comments expressed or implied by such Forward-Looking Information are subject to a number of risks, uncertainties, and conditions, many of which are outside of WELL's control, and undue reliance should not be placed on such information. Forward-Looking Information is qualified in its entirety by inherent risks and uncertainties, including: direct and indirect material adverse effects from adverse market conditions; risks inherent in the primary healthcare and technology sectors generally; regulatory and legislative changes; that market competition may affect the business, results and financial condition of WELL; and other risk factors identified in documents filed by WELL under its profile at www.sedarplus.ca, including its most recent Annual Information Form and its Management's Discussion and Analysis. Except as required by securities law, WELL does not assume any obligation to update or revise any forward-looking information, whether as a result of new information, events or otherwise.For further information:Pardeep Sangha
Vice President, Investor Relations